Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge.

Source:http://linkedlifedata.com/resource/pubmed/id/21325402

Download in:

View as

General Info

PMID
21325402